Pharmafile Logo
Pharmafocus logo
Advanced Search

Astellas Pharma Europe

Showing 4 posts of 4 posts found.

astellas_main_web_2_0

Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint

December 18, 2015
Medical Communications ABPI Code, Astellas, Astellas Pharma Europe, PMCPA, Prescription Medicines Code of Practice Authority

The Prescription Medicines Code of Practice Authority is investigating Astellas for deliberately providing an ‘incomplete and misleading’ response to a …

News

Astellas eyes oncology growth

April 21, 2010
Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …

News
OSI Pharmaceuticals

Astellas moves in on OSI Pharmaceuticals

March 2, 2010
Sales and Marketing Astellas, Astellas Pharma Europe, OSI

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …

News

Working Life: Kay Spiller

February 13, 2009
Sales and Marketing Astellas Pharma Europe, marketing

How did you find your way into your role? This was really through what I would describe as the 'traditional' …

Feature
The Gateway to Local Adoption Series

Latest content

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026